Outlook Therapeutics
OTLK
OTLK
49 hedge funds and large institutions have $30.3M invested in Outlook Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.15% more ownership
Funds ownership: 0.23% → 0.39% (+0.15%)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.13M | |
| 2 | +$3.92M | |
| 3 | +$2.4M | |
| 4 |
Renaissance Technologies
New York
|
+$1.75M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
Top Sellers
| 1 | -$221K | |
| 2 | -$210K | |
| 3 | -$97.5K | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$35K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$30K |